ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,339.23
-0.37%
Dow Jones
39,065.26
-1.53%
Gold vs US Dollar
2,333.355
0.05%
Brent Oil
81.125
-0.23%
Bitcoin
67,644.44
-0.41%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Elevai Labs Inc (ELAB) Share Price

ELAB Elevai Labs Inc

0.6533
-0.0117 (-1.76%)
24 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Elevai Labs Inc NASDAQ:ELAB NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.0117 -1.76 0.6533 0.6532 0.66 0.6698 0.65 0.66 111,835 23:43:50   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 1.71M -4.3M -0.2482 -2.66 11.44M
 Type  Size  Price  Time  Units 
 20 127 0.6533 23:43:50 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ELAB News
22/05/202421:15GLOBEElevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference
15/05/202421:30GLOBEElevai Labs Inc. Reports First Quarter 2024 Financial Results
15/05/202421:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202421:01EDGAR2Form 8-K - Current report
02/05/202413:30GLOBEElevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
01/05/202421:00GLOBEElevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare
01/05/202414:00GLOBEElevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
Period
Draw mode
Data Downloads for ELAB

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Elevai Labs Inc Articles